91 related articles for article (PubMed ID: 2140582)
1. Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.
Opal SM; Cross AS; Kelly NM; Sadoff JC; Bodmer MW; Palardy JE; Victor GH
J Infect Dis; 1990 Jun; 161(6):1148-52. PubMed ID: 2140582
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of anti-endotoxin monoclonal antibody E5 alone or in combination with ciprofloxacin in neutropenic rats with Pseudomonas sepsis.
Romulo RL; Palardy JE; Opal SM
J Infect Dis; 1993 Jan; 167(1):126-30. PubMed ID: 8418159
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.
Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW
J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775
[TBL] [Abstract][Full Text] [Related]
4. Oral ciprofloxacin and a monoclonal antibody to lipopolysaccharide protect leukopenic rats from lethal infection with Pseudomonas aeruginosa.
Collins HH; Cross AS; Dobek A; Opal SM; McClain JB; Sadoff JC
J Infect Dis; 1989 Jun; 159(6):1073-82. PubMed ID: 2723454
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of combination immunotherapy in experimental Pseudomonas sepsis.
Cross AS; Opal SM; Palardy JE; Bodmer MW; Sadoff JC
J Infect Dis; 1993 Jan; 167(1):112-8. PubMed ID: 8418157
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
Fu KP; Hetzel N; Gregory FJ; Hung PP
J Antimicrob Chemother; 1987 Oct; 20(4):541-6. PubMed ID: 3680089
[TBL] [Abstract][Full Text] [Related]
7. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
Pennington JE; Small GJ
J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice.
Ulrich E; Trautmann M; Krause B; Bauernfeind A; Hahn H
Infection; 1989; 17(5):311-5. PubMed ID: 2599653
[TBL] [Abstract][Full Text] [Related]
9. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
Bendig JW; Kyle PW; Giangrande PL; Samson DM; Azadian BS
J R Soc Med; 1987 May; 80(5):316-7. PubMed ID: 3112380
[No Abstract] [Full Text] [Related]
10. Therapy of neutropenic rats infected with Pseudomonas aeruginosa.
Lumish RM; Norden CW
J Infect Dis; 1976 May; 133(5):538-47. PubMed ID: 816976
[TBL] [Abstract][Full Text] [Related]
11. A human monoclonal antibody that protects mice against Pseudomonas-induced pneumonia.
Zweerink HJ; Detolla LJ; Gammon MC; Hutchison CF; Puckett JM; Sigal NH
J Infect Dis; 1990 Jul; 162(1):254-7. PubMed ID: 2113078
[TBL] [Abstract][Full Text] [Related]
12. Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
Johnson DE; Calia FM; Snyder MJ; Warren JW; Schimpff SC
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():89-96. PubMed ID: 6583199
[TBL] [Abstract][Full Text] [Related]
13. Combined pre-immunization and granulocyte transfusion therapy for treatment of pseudomonas septicemia in neutropenic dogs.
Harvath L; Andersen BR; Zander AR; Epstein RB
J Lab Clin Med; 1976 May; 87(5):840-7. PubMed ID: 1270891
[TBL] [Abstract][Full Text] [Related]
14. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients.
Verhagen C; de Pauw BE; Donnelly JP; Williams KJ; de Witte T; Janssen TH
J Infect; 1986 Sep; 13(2):125-31. PubMed ID: 3093589
[TBL] [Abstract][Full Text] [Related]
16. Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.
Oishi K; Sonoda F; Iwagaki A; Kobayashi S; Nagatake T; Matsumoto K
Antimicrob Agents Chemother; 1992 Jul; 36(7):1352-7. PubMed ID: 1324643
[TBL] [Abstract][Full Text] [Related]
17. Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
Collins MS; Ladehoff D; Mehton NS
Antibiot Chemother (1971); 1991; 44():185-95. PubMed ID: 1801636
[No Abstract] [Full Text] [Related]
18. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
Shyu WC; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
Ishibashi K; Yamaguchi O; Shiraiwa Y; Ogihara M; Shigeta S
J Urol; 1996 Jun; 155(6):2094-7. PubMed ID: 8618343
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia.
Ziegler EJ; Douglas H
J Infect Dis; 1979 Mar; 139(3):288-96. PubMed ID: 109545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
